Skip to main content
. 2019 Jan 29;17(4):2703–2707. doi: 10.3892/etm.2019.7215

Table I.

Patients' general medical records [n (%)].

Variables Experimental group (n=116) Control group (n=103) χ2 value P-value
Sex 0.064 0.800
  Male 74 (63.79) 64 (62.14)
  Female 42 (36.21) 39 (37.86)
Age (years) 0.225 0.635
  ≤63 69 (59.48) 58 (56.31)
  >63 47 (40.52) 45 (43.69)
BMI (kg/m2) 0.061 0.805
  ≤21 65 (56.03) 56 (54.37)
  >21 51 (43.97) 47 (45.63)
Alcohol consumption 0.019 0.891
  Yes 72 (62.07) 63 (61.17)
  No 44 (37.93) 40 (38.83)
Tumor location 0.029 0.986
  Intrahepatic cholangiocarcinoma 35 (30.17) 30 (29.13)
  Hilar cholangiocarcinoma 42 (36.21) 38 (36.89)
  Distal cholangiocarcinoma 39 (33.62) 35 (33.98)
Pathological type 0.197 0.978
  Papillary carcinoma 41 (35.34) 36 (34.95)
  Sclerosing cancer 22 (18.97) 19 (18.45)
  Nodular carcinoma 32 (27.59) 27 (26.21)
  Diffuse invasive carcinoma 21 (18.10) 21 (20.39)